Results

Total Results: 518 records

Showing results for "renal".

221. Behavioral Programs for Type 2 Diabetes Mellitus: Current State of the Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
     November 01, 2016 - regulation; medication adherence; or self-monitoring for diabetic complications (foot exam, eye exam, and renal

222. Hip-Fracture-Pain Clinician (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
     May 01, 2011 - Serious adverse events such as myocardial infarction, stroke, and renal failure were either rarely reported

223. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/reporting.ppt
     September 01, 2009 - Example: Randomized clinical trials studying the administration of hepatitis B vaccine to CRF [chronic renal … …Renal transplant patients were excluded from this review. Schroth RJ, et al. … Hepatitis B vaccination for patients with chromic renal failure. … Hepatitis B vaccination for patients with chromic renal failure. … Hepatitis B vaccination for patients with chromic renal failure.

224. Pharmacotherapy for Adults With Alcohol Use Disorder (AUD) in Outpatient Settings | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician
     January 01, 2021 - Mechanism of Action Common Adverse Effects Contraindications a Dose adjustment for moderate renal … hyperactive glutamatergic n-methyl-d-aspartate receptors Anxiety Diarrhea Vomiting Severe renal

225. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - Renal stones were within scope, but no placebo-controlled treatment RCTs reported on this outcome. … We have modified the text on use in renal impairment. … , patients taking either febuxostat or allopurinol with mild renal impairment achieved higher rates … disease, and of intervening upon hyperuricemia demonstrating renal benefits. … However, we did examine our included studies for renal outcomes and added these to the text.

226. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - medications, nonsignificant results were observed for withdrawal due to adverse events, bleeding, renal … No statistically significant effects were observed in withdrawal due to adverse events, bleeding, renal … controlled or absent cholesterolemia and hypertension; no hx of diabetes, CVD, intervention, or renal … Adverse effects: No significant change in hepatic, thyroid, renal, or hematologic function. … No statistically significant effects were observed in withdrawal due to adverse events, bleeding, renal

227. Chronic Urinary Retention (CUR) Treatment | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/chronic-urinary-retention/research-protocol
     December 01, 2020 - Acute urinary retention typically is associated with lower abdominal pain and may lead to infection, renal … Commonly performed tests include: Urinalysis Urine culture Measures of renal function Prostate-specific … antigen test Urodynamic testing Renal, bladder, or transrectal prostate ultrasound Brain or pelvic

228. Vitamin D and Calcium: A Systematic Review of Health Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/vitamin-d-calcium/research-protocol
     December 01, 2019 - cardiovascular diseases, cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal … Adverse effects of intervention(s) All-cause mortality Cancer and cancer-specific mortality Renal … upper intake levels (ULs/AEs; specifically, all-cause mortality; cancer and cancer-specific mortality, renal

229. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
     January 01, 2007 - For instance, biguanides such as metformin are contraindicated in patients with renal or liver failure … factors (e.g., race/ethnicity, age greater than 65 years, or gender) or comorbid conditions (e.g., renal … did not have enough information on subjects taking metformin with chronic conditions such as chronic renal … areas to focus on would be effects of medications in the elderly and in subjects with and without renal … based on demographic factors (e.g., race/ethnicity, age >65 years, or gender) or comorbidities (e.g., renal

230. Fiber-Intake-Draft-Report-Appendix-C (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fiber-intake-draft-report-appendix-c.xlsx
     January 01, 2024 - Reported (Yes COI) Community 40–65 y; BMI 20–35 kg/m2, habitual WG consumption <24 g/d Diabetes, heart, renal … juice. gastrointestinal disease (12 mo); cancer history; abdominal surgery; inflammatory bowel disease; renal … cross-over < 2008 Industry funding of study NR Community NR history of diabetes, gastrointestinal, renal … BMI: 19-32; postmenopausal women; taking hypolipidemic agents; people with diabetes, or hepatic, or renal … RCT cross-over < 2003 No industry funding Reported (No COI) Community 40–65 y; no gastroin testinal, renal

231. Chronic-urinary-retention-protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
     November 19, 2012 - effort to do so.1 AUR typically is associated with lower abdominal pain and may lead to infection, renal … Commonly performed tests include: • urinalysis (UA) • urine culture • measures of renal function … • renal

232. Geographic Variation in Carotid Endarterectomy and Carotid Stenting Among Medicare Beneficiaries, 2003-2006 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cardiology-health-outcomes/research
     January 01, 2019 - 290.x, 294.1, and 331.2), diabetes mellitus (code 250), hypertension (codes 401-405 and 437.2), and renal … 418 (90.6) 6820 (92.7) Peripheral vascular disease — 24 625 (36.9) 3386 (46.0) Renal … (1.52-1.64) b Previous carotid endarterectomy 1.12 (1.05-1.20) c 3.06 (2.65-3.53) b Renal

233. Diabetes-Foot-Ulcer-Amputation-Prevalence Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
     February 01, 2011 - Those with diabetes are expected to suffer from several associ- ated medical complications, such as renal … The prevalence of LEA in nonelderly diabetics with PAD (many of whom likely have end-stage renal disease

234. Methods White Paper: Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
     April 01, 2021 - Denervation in the Medicare Population35 What is the evidence for renal denervation effectiveness … Management of Renal Masses and Localized Renal Cancer36 Efficacy and comparative efficacy of different … interventions for the management of a renal mass suspicious for localized renal cell carcinoma … Renal denervation in the medicare population. … Management of renal masses and localized renal cancer: systematic review and meta- analysis.

235. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
     January 01, 2018 - Events CV Events GI GI GI GI Liver Dysfunction Liver Dysfunction Liver Dysfunction Liver Dysfunction Renal … Dysfunction Renal Dysfunction Renal Dysfunction Renal Dysfunction Application Site Reaction (additional … Events CV Events GI GI GI GI Liver Dysfunction Liver Dysfunction Liver Dysfunction Liver Dysfunction Renal … Dysfunction Renal Dysfunction Renal Dysfunction Renal Dysfunction Application Site Reaction (additional

236. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
     January 01, 2015 - pressure and heart rate, and for studies that include a comparison with SGLT-2 inhibitors, impaired renal … • We included studies addressing the following safety outcomes for KQ3: – Liver injury – Impaired renal … The exclusion criteria were generally similar for most trials: significant renal, cardiovasular, and … described in prior reviews.18, 68 The evidence on SGLT-2 inhibitor comparisons regarding fractures, renal … Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes

237. CER 45 Self-Measured Blood Pressure Monitoring Comparative Effectiveness Surveillance Final 4.7.16 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
     April 11, 2016 - Reduced"effect"of"percutaneous" renal"denervation"on"blood"pressure"in"patients"with"isolated"systolic"hypertension … Blood"pressure"changes"after"renal"denervation"at"10"European"expert" centers." … "(2015)."4a.03:"Catheter' Based"Renal"Denervation"for"Resistant"Hypertension:"24"Month"Results"of"the"Enlightn"I … Eligibility"for"percutaneous" renal"denervation:"the"importance"of"a"systematic"screening." … Clinical(Outcomes( SOE:(Insufficient( ( One$quality$C$study$reported$ on$mortality$and$end"stage$ renal

238. For the disabled and elderly with multiple comorbidities, what is the comparative effectiveness of physician housecalls on outcomes and total cost? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-the-disabled-and-elderly-with-multiple-comorbidities-what-is-the-comparative-effectiveness-of-physician-housecalls-on-outcomes-and-total-cost
     November 01, 2017 - Specific diseases such as Alzheimer's, diabetes, CHF, CAD, COPD and chronic renal failure are highly

239. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol
     December 01, 2019 - coronary syndrome Subpopulations, including: patients with comorbid conditions, such as dementia, or renal … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … Subgroups of potential interest include: Patients who have comorbid conditions such as dementia or renal … Food and Drug Administration GWTG Get With The Guidelines HAS-BLED hypertension, abnormal renal/liver

240. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - percent being cleared by the kidneys, and has a plasma half-life of 25 minutes in patients with normal renal … disease:  Subgroups by age, sex, weight, body mass index, diabetes, heart failure, previous stroke, renal … characteristics • Age • Sex • Diabetes • Weight • Body mass index • Heart failure • Previous stroke • Renal … characteristics including age, sex, weight, body mass index, diabetes, heart failure, previous stroke, renal … minutes and then continued at 0.1 mcg/kg/min for 12 to 24 hr following PCI Patients with severe renal